Taking Lessons From Hematology Experts in Tampa

By
Article

We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.

We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.

Recent Videos
David Barrett, JD, the chief executive officer of ASGCT
Georg Schett, MD, vice president research and chair of internal medicine at the University of Erlangen – Nuremberg
David Barrett, JD, the chief executive officer of ASGCT
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Caroline Diorio, MD, FRCPC, FAAP, an attending physician at the Cancer Center at Children's Hospital of Philadelphia
R. Nolan Townsend; Sandi See Tai, MD; Kim G. Johnson, MD
Daniela van Eickels, MD, PhD, MPH, the vice president and head of medical affairs for Bristol Myers Squibb’s Cell Therapy Organization
Paul Melmeyer, MPP, the executive vice president of public policy & advocacy at MDA
Daniela van Eickels, MD, PhD, MPH, the vice president and head of medical affairs for Bristol Myers Squibb’s Cell Therapy Organization
Related Content
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – November 22, 2024

CGTLive Staff
November 22nd 2024
Article

Review top news and interview highlights from the week ending November 22, 2024.

Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center

Evaluating Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma

Bhagirathbhai Dholaria, MBBS;Noah Stansfield
November 21st 2024
Article

Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center, discussed interim data from the phase 1/1b clinical trial evaluating Poseida's CAR-T.

Molly Borchardt, PharmD

Improving Patient Access to Cell Therapy Through Decentralized Manufacturing

Molly Borchardt, PharmD;Phil Cyr, MPH;Erin Lopata, PharmD, MPH;Jason Foster, MBA
November 21st 2024
Article

Decentralized manufacturing could transform cell therapy delivery by reducing delays, costs, and logistical hurdles to improve patient outcomes.

World Pancreatic Cancer Day 2024: Looking Back at Progress in Cell and Gene Therapy

World Pancreatic Cancer Day 2024: Looking Back at Progress in Cell and Gene Therapy

CGTLive Staff
November 21st 2024
Article

In observance of World Pancreatic Cancer Day, held on the third Thursday of November each year, we took a look back at the past year's news in cell and gene therapy for pancreatic cancer indications.

Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 20, 2024

Noah Stansfield
November 20th 2024
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease

First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease

Noah Stansfield
November 19th 2024
Article

Adicet is also presenting biomarker data at ACR Convergance from a trial evaluating ADI-001 in B-cell malignancies that may indicate its potential to treat autoimmune diseases.

© 2024 MJH Life Sciences

All rights reserved.